"10.1371_journal.pone.0111125","plos one","2014-11-07T00:00:00Z","Li-Di Xu; Susanne Muller; Srinivasan R Thoppe; Fredrik Hellborg; Lena Kanter; Mikael Lerner; Biying Zheng; Svetlana Bajalica Lagercrantz; Dan Grand√©r; Keng Ling Wallin; Klas G Wiman; Catharina Larsson; Sonia Andersson","Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska University Hospital-Solna, Stockholm, Sweden; Department of Womens and Childrens Health, Division of Obstetrics and Gynecology, Karolinska University Hospital-Solna, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital-Solna, Stockholm, Sweden","Conceived and designed the experiments: LDX DG KGW CL SA. Performed the experiments: LDX SM SRT FH ML BZ KLW. Analyzed the data: LDX SM LK SRT FH ML BZ SBL KLW KGW CL SA. Contributed reagents/materials/analysis tools: DG KGW CL SA. Wrote the paper: LDX SM KLW KGW CL SA. Final approval of the version to be published: LDX SM KGW CL SA.","Li-Di Xu has read the journals policy and the authors of this manuscript have the following competing interests: Klas G. Wiman is cofounder, shareholder, and board member of Aprea AB, a company that develops p53-based cancer therapy.","2014","11","Li-Di Xu","LDX",13,TRUE,5,7,12,6,TRUE,TRUE,FALSE,0,NA,FALSE
